---
layout: post
title: "Approval of Previously Withdrawn New Drug Application for WELLCOVORIN (Leucovorin Calcium) Tablets"
date: 2026-02-04 21:49:24 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-18510
original_published: 2025-09-24 00:00:00 +0000
significance: 8.00
---

# Approval of Previously Withdrawn New Drug Application for WELLCOVORIN (Leucovorin Calcium) Tablets

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** September 24, 2025 00:00 UTC
**Document Number:** 2025-18510

## Summary

The Food and Drug Administration (FDA or Agency) is announcing approval of the previously withdrawn new drug application (NDA) for Wellcovorin (leucovorin calcium) tablets, equivalent to (EQ) 5 milligrams (mg) base and EQ 25 mg base. FDA is initiating this action on the basis of new data and is required to publish notice of approval of an NDA for which the Agency had previously withdrawn approval.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/09/24/2025-18510/approval-of-previously-withdrawn-new-drug-application-for-wellcovorin-leucovorin-calcium-tablets)
- API: https://www.federalregister.gov/api/v1/documents/2025-18510

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
